REIT - Office
Compare Stocks
5 / 10Stock Comparison
NYC vs SILA vs CHCT vs CMCT vs GMRE
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Office
REIT - Healthcare Facilities
NYC vs SILA vs CHCT vs CMCT vs GMRE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Office | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Office | REIT - Healthcare Facilities |
| Market Cap | $20M | $1.69B | $505M | $6M | $94M |
| Revenue (TTM) | $39M | $198M | $122M | $117M | $148M |
| Net Income (TTM) | $-21M | $33M | $6M | $-39M | $2M |
| Gross Margin | 6.2% | 87.9% | 62.8% | -10.3% | 68.8% |
| Operating Margin | -168.6% | 34.5% | 31.3% | 7.1% | 24.9% |
| Forward P/E | — | 47.0x | 37.6x | — | 595.7x |
| Total Debt | $403M | $721M | $536M | $510M | $654M |
| Cash & Equiv. | $10M | $32M | $3M | $15M | $7M |
NYC vs SILA vs CHCT vs CMCT vs GMRE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 24 | May 26 | Return |
|---|---|---|---|
| American Strategic … (NYC) | 100 | 84.4 | -15.6% |
| Sila Realty Trust, … (SILA) | 100 | 144.4 | +44.4% |
| Community Healthcar… (CHCT) | 100 | 75.6 | -24.4% |
| Creative Media & Co… (CMCT) | 100 | 0.0 | -100.0% |
| Global Medical REIT… (GMRE) | 100 | 76.3 | -23.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NYC vs SILA vs CHCT vs CMCT vs GMRE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NYC lags the leaders in this set but could rank higher in a more targeted comparison.
SILA carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.34, Low D/E 54.2%, current ratio 5488.22x
- Beta 0.34, yield 5.2%, current ratio 5488.22x
- 5.7% FFO/revenue growth vs CMCT's -6.3%
- 16.8% margin vs NYC's -53.6%
CHCT is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 4.7%, EPS growth 133.7%, 3Y rev CAGR 7.5%
- Lower P/E (37.6x vs 595.7x)
CMCT ranks third and is worth considering specifically for dividends.
- 100.0% yield, vs CHCT's 11.3%, (1 stock pays no dividend)
GMRE is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.48, yield 63.5%
- 308.1% 10Y total return vs SILA's 55.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.7% FFO/revenue growth vs CMCT's -6.3% | |
| Value | Lower P/E (37.6x vs 595.7x) | |
| Quality / Margins | 16.8% margin vs NYC's -53.6% | |
| Stability / Safety | Beta 0.34 vs CMCT's 1.20, lower leverage | |
| Dividends | 100.0% yield, vs CHCT's 11.3%, (1 stock pays no dividend) | |
| Momentum (1Y) | +25.9% vs CMCT's -99.0% | |
| Efficiency (ROA) | 1.6% ROA vs NYC's -4.7%, ROIC 2.5% vs -15.8% |
NYC vs SILA vs CHCT vs CMCT vs GMRE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
NYC vs SILA vs CHCT vs CMCT vs GMRE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SILA leads in 3 of 6 categories
NYC leads 0 • CHCT leads 0 • CMCT leads 0 • GMRE leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SILA leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SILA is the larger business by revenue, generating $198M annually — 5.0x NYC's $39M. SILA is the more profitable business, keeping 16.8% of every revenue dollar as net income compared to NYC's -53.6%. On growth, GMRE holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $39M | $198M | $122M | $117M | $148M |
| EBITDAEarnings before interest/tax | -$53M | $145M | $82M | $35M | $95M |
| Net IncomeAfter-tax profit | -$21M | $33M | $6M | -$39M | $2M |
| Free Cash FlowCash after capex | -$13M | $111M | $60M | -$15M | $19M |
| Gross MarginGross profit ÷ Revenue | +6.2% | +87.9% | +62.8% | -10.3% | +68.8% |
| Operating MarginEBIT ÷ Revenue | -168.6% | +34.5% | +31.3% | +7.1% | +24.9% |
| Net MarginNet income ÷ Revenue | -53.6% | +16.8% | +5.0% | -33.4% | +1.7% |
| FCF MarginFCF ÷ Revenue | -33.4% | +56.1% | +49.4% | -12.9% | +12.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +8.9% | +4.8% | +3.6% | +18.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.0% | -55.0% | +124.4% | +97.5% | -166.2% |
Valuation Metrics
Evenly matched — CHCT and CMCT each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 51.0x trailing earnings, SILA trades at a 78% valuation discount to CHCT's 228.4x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than SILA's 16.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $20M | $1.7B | $505M | $6M | $94M |
| Enterprise ValueMkt cap + debt − cash | $413M | $2.4B | $1.0B | $500M | $741M |
| Trailing P/EPrice ÷ TTM EPS | -0.14x | 50.97x | 228.42x | -0.10x | 115.29x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 47.05x | 37.62x | — | 595.67x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 16.76x | 16.27x | 14.15x | 8.35x |
| Price / SalesMarket cap ÷ Revenue | 0.33x | 8.55x | 4.17x | 0.05x | 0.68x |
| Price / BookPrice ÷ Book value/share | 0.23x | 1.28x | 1.11x | 0.02x | 0.17x |
| Price / FCFMarket cap ÷ FCF | — | 15.24x | 8.95x | — | — |
Profitability & Efficiency
SILA leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
SILA delivers a 2.4% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $-30 for NYC. SILA carries lower financial leverage with a 0.54x debt-to-equity ratio, signaling a more conservative balance sheet compared to NYC's 4.71x. On the Piotroski fundamental quality scale (0–9), SILA scores 7/9 vs CMCT's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -29.6% | +2.4% | +1.4% | -13.4% | +0.5% |
| ROA (TTM)Return on assets | -4.7% | +1.6% | +0.6% | -4.5% | +0.2% |
| ROICReturn on invested capital | -15.8% | +2.5% | +1.6% | +0.8% | +2.0% |
| ROCEReturn on capital employed | -20.8% | +3.7% | +2.8% | +1.1% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 7 | 5 | 2 | 4 |
| Debt / EquityFinancial leverage | 4.71x | 0.54x | 1.25x | 1.91x | 1.18x |
| Net DebtTotal debt minus cash | $393M | $689M | $533M | $494M | $647M |
| Cash & Equiv.Liquid assets | $10M | $32M | $3M | $15M | $7M |
| Total DebtShort + long-term debt | $403M | $721M | $536M | $510M | $654M |
| Interest CoverageEBIT ÷ Interest expense | -6.22x | 2.01x | 1.15x | 0.03x | 1.14x |
Total Returns (Dividends Reinvested)
SILA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SILA five years ago would be worth $15,222 today (with dividends reinvested), compared to $402 for CMCT. Over the past 12 months, SILA leads with a +25.9% total return vs CMCT's -99.0%. The 3-year compound annual growth rate (CAGR) favors SILA at 13.7% vs CMCT's -65.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -6.0% | +31.8% | +11.2% | -98.1% | +6.9% |
| 1-Year ReturnPast 12 months | -30.7% | +25.9% | +14.5% | -99.0% | +0.1% |
| 3-Year ReturnCumulative with dividends | -6.0% | +47.0% | -36.1% | -95.9% | +5.6% |
| 5-Year ReturnCumulative with dividends | -88.1% | +52.2% | -45.6% | -96.0% | -21.4% |
| 10-Year ReturnCumulative with dividends | -93.8% | +55.9% | +83.9% | -59.4% | +308.1% |
| CAGR (3Y)Annualised 3-year return | -2.1% | +13.7% | -13.9% | -65.5% | +1.8% |
Risk & Volatility
Evenly matched — NYC and SILA each lead in 1 of 2 comparable metrics.
Risk & Volatility
NYC is the less volatile stock with a -0.26 beta — it tends to amplify market swings less than CMCT's 1.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SILA currently trades 99.8% from its 52-week high vs CMCT's 0.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.26x | 0.34x | 0.60x | 1.20x | 0.48x |
| 52-Week HighHighest price in past year | $16.30 | $30.63 | $18.22 | $1441.00 | $39.93 |
| 52-Week LowLowest price in past year | $7.03 | $21.94 | $13.23 | $3.60 | $29.05 |
| % of 52W HighCurrent price vs 52-week peak | +49.6% | +99.8% | +97.0% | +0.5% | +89.5% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 87.8 | 56.9 | 21.2 | 52.7 |
| Avg Volume (50D)Average daily shares traded | 2K | 741K | 228K | 3.9M | 130K |
Analyst Outlook
Evenly matched — CHCT and CMCT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SILA as "Buy", CHCT as "Hold", GMRE as "Buy". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs -3.0% for SILA (target: $30). For income investors, CMCT offers the higher dividend yield at 100.00% vs SILA's 5.23%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | — | Buy |
| Price TargetConsensus 12-month target | — | $29.67 | $18.50 | — | $40.00 |
| # AnalystsCovering analysts | — | 4 | 16 | — | 22 |
| Dividend YieldAnnual dividend ÷ price | — | +5.2% | +11.3% | +100.0% | +63.5% |
| Dividend StreakConsecutive years of raises | 0 | 3 | 11 | 0 | 5 |
| Dividend / ShareAnnual DPS | — | $1.60 | $2.00 | $23.89 | $22.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +0.5% | +0.4% | +2.8% | 0.0% |
SILA leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 3 categories are tied.
NYC vs SILA vs CHCT vs CMCT vs GMRE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NYC or SILA or CHCT or CMCT or GMRE a better buy right now?
For growth investors, Sila Realty Trust, Inc.
(SILA) is the stronger pick with 5. 7% revenue growth year-over-year, versus -6. 3% for Creative Media & Community Trust Corporation (CMCT). Sila Realty Trust, Inc. (SILA) offers the better valuation at 51. 0x trailing P/E (47. 0x forward), making it the more compelling value choice. Analysts rate Sila Realty Trust, Inc. (SILA) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NYC or SILA or CHCT or CMCT or GMRE?
On trailing P/E, Sila Realty Trust, Inc.
(SILA) is the cheapest at 51. 0x versus Community Healthcare Trust Incorporated at 228. 4x. On forward P/E, Community Healthcare Trust Incorporated is actually cheaper at 37. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — NYC or SILA or CHCT or CMCT or GMRE?
Over the past 5 years, Sila Realty Trust, Inc.
(SILA) delivered a total return of +52. 2%, compared to -96. 0% for Creative Media & Community Trust Corporation (CMCT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus NYC's -93. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NYC or SILA or CHCT or CMCT or GMRE?
By beta (market sensitivity over 5 years), American Strategic Investment Co.
(NYC) is the lower-risk stock at -0. 26β versus Creative Media & Community Trust Corporation's 1. 20β — meaning CMCT is approximately -556% more volatile than NYC relative to the S&P 500. On balance sheet safety, Sila Realty Trust, Inc. (SILA) carries a lower debt/equity ratio of 54% versus 5% for American Strategic Investment Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — NYC or SILA or CHCT or CMCT or GMRE?
By revenue growth (latest reported year), Sila Realty Trust, Inc.
(SILA) is pulling ahead at 5. 7% versus -6. 3% for Creative Media & Community Trust Corporation (CMCT). On earnings-per-share growth, the picture is similar: Community Healthcare Trust Incorporated grew EPS 133. 7% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, CHCT leads at 7. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NYC or SILA or CHCT or CMCT or GMRE?
Sila Realty Trust, Inc.
(SILA) is the more profitable company, earning 16. 8% net margin versus -228. 3% for American Strategic Investment Co. — meaning it keeps 16. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SILA leads at 32. 9% versus -196. 9% for NYC. At the gross margin level — before operating expenses — SILA leads at 87. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NYC or SILA or CHCT or CMCT or GMRE more undervalued right now?
On forward earnings alone, Community Healthcare Trust Incorporated (CHCT) trades at 37.
6x forward P/E versus 595. 7x for Global Medical REIT Inc. — 558. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.
08Which pays a better dividend — NYC or SILA or CHCT or CMCT or GMRE?
In this comparison, CMCT (100.
0% yield), GMRE (63. 5% yield), CHCT (11. 3% yield), SILA (5. 2% yield) pay a dividend. NYC does not pay a meaningful dividend and should not be held primarily for income.
09Is NYC or SILA or CHCT or CMCT or GMRE better for a retirement portfolio?
For long-horizon retirement investors, Global Medical REIT Inc.
(GMRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 63. 5% yield, +308. 1% 10Y return). Both have compounded well over 10 years (GMRE: +308. 1%, CMCT: -59. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NYC and SILA and CHCT and CMCT and GMRE?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NYC is a small-cap quality compounder stock; SILA is a small-cap income-oriented stock; CHCT is a small-cap income-oriented stock; CMCT is a small-cap income-oriented stock; GMRE is a small-cap income-oriented stock. SILA, CHCT, CMCT, GMRE pay a dividend while NYC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.